Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use

Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use

US Patent 10092567 · Granted Oct 9, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of breast cancer using combination therapies comprising an ATP competi2024
Method and apparatus for SSD storage access2024
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhib2023
Treatment of breast cancer using combination therapies comprising an ATP competi2023
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhib2022
Method and apparatus for SSD storage access2021
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhib2021
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhib2021
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer2021
Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibi2021
Methods and compositions for detecting and treating drug resistant AKT mutant2020
System, apparatus for content delivery for internet traffic and methods thereof2018